We believe in innovation through research. BITS research enterprise encourages collaborations that make innovations and research advances possible. By bridging basic and applied research, we’re helping create new areas of research and building the foundations for industries of the future.
Design & Synthesis of Mycobacterium UDG Inhibitors
Computational design, synthesis and screening of non-hydroxamate lipophilic DXR inhibitors as potential antibacterial/antimalarial/anti-TB agents
Design, Synthesis, Biological Evaluation and Molecular modelling studies of Indolyl Oxoacetamide-Quinazoline based hybrid analogs as potential pancreatic lipase inhibitors for Obesity treatment
APREMILAST LOADED HALLOYSITE NANOTUBES COMPOSITE ENCAPSULATED IN ELECTROSPUN NANOPATCHES A NOVEL TREATMENT FOR PSORIASIS
Design and evaluation of a lowcost lab-on-chip noninvasive device for diagnosis of Psoriasis skin disorder: investigation of skin elasticity in psoriatic disease condition and correlation with treatment efficacy of designed nanoformulations
Rod-shaped polymeric nanoparticles for targeted delivery of artemisinin-derivatives to plasmodium-infected erythrocytes for improved intravenous therapy of cerebral malaria
Self assembling pH-sensitive temozolomide-lipoic acid conjugate nanomedicine for treatment of glioblastoma multiforme
cRGD decorated lipo-polymeric nanoplexes of CRISPR/Cas9 ribonucleoprotein (RNP) for the management of retinal dystrophic conditions
Peptide-decorated pH-sensitive nano-conjugate hybrid micelles for co-delivery of temozolamide and an autophagy inducer, rapamycin, for treatment of glioblastoma multiforme
Activity targeted nano-formulations for co-delivery of a taxane and antioxidant molecule, alpha acid, for treating breast cancer
Peptide-tethered multifunctional cationic nanocomplexes for delivery of IL-1 receptor antagonist for treatment of type 2 diabetes mellitus
Gel-based composite formulation containing asiaticoside and neurotensin for rapid healing of diabetic wounds